Schedule 13G Filing by Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC for Enveric Biosciences, Inc.

This Schedule 13G filing, submitted by Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC, reports their beneficial ownership of shares in Enveric Biosciences, Inc. As of September 24, 2025, the reporting persons collectively own 19,333 shares of common stock, representing approximately 0.4% of the outstanding shares. The filing details the ownership structure, including warrants held by Intracoastal Capital LLC that are subject to blocker provisions limiting exercise to prevent ownership exceeding 4.99% of the common stock. The filing is made pursuant to Rule 13d-1(c) and includes a joint filing agreement.